R.A.W. will be at  MIOLive  2026 in Rome on January 26–27, at the Auditorium Centro Congressi Europa, Università Cattolica del Sacro Cuore – Fondazione Policlinico Universitario A. Gemelli IRCCS.  This is a major international event dedicated to interventional oncology, and a great opportunity to learn about our technologies,  Endosight  and  Ablation-fit .  Click here to take a look at the MIOLive 2026 scientific program 👉  https://lnkd.in/dzwDuXEA    See you at our stand i

R.A.W. will participate in ICIR SIRM  2025, taking place on November 20-22 in Turin. During the congress, we'll present how Endosight  and Ablation-fit  are redefining precision, guidance, and intra-procedural assessment in interventional oncology. Our team will be available throughout the event to meet clinicians and professionals interested in discovering our technologies and exploring future collaborations.   See you at ICIR SIRM 2025! Download here the program: #Endosight

The ACCLAIM trial marks a turning point for ablation verification software. The recent publication of the ACCLAIM study protocol in Trials confirms that software-based verification of ablation margins is becoming an essential component of interventional oncology practice. This international, multicenter trial promoted by the Society of Interventional Oncology establishes a structured protocol for real-time 3D confirmation of complete ablation with margins ≥5 mm, using CE- an